| View |
|
DRP-13713-01
|
Losartan Potassium + Hydrochlorothiazide
|
None
|
100 mg/25 mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 August 2023
|
30 March 2028
|
| View |
|
DRP-5909-06
|
Pantoprazole (as sodium sesquihydrate)
|
Pantokem
|
40 mg
|
Enteric-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
22 July 2023
|
12 January 2025
|
| View |
|
DRP-7359-13
|
Spironolactone
|
Spirenze
|
25 mg
|
Tablet
|
-
|
Maxtar Bio-Genics
|
India
|
CLIDP Conversion
|
01 August 2023
|
04 October 2026
|
| View |
DRP-7361-07_PI_01.pdf
|
DRP-7361-07
|
Spironolactone
|
Aldax
|
50 mg
|
Tablet
|
-
|
Maxtar Bio-Genics
|
India
|
CLIDP Conversion
|
17 March 2023
|
04 October 2026
|
| View |
|
DRP-7361-08
|
Spironolactone
|
Spirenze
|
50 mg
|
Tablet
|
-
|
Maxtar Bio-Genics
|
India
|
CLIDP Conversion
|
31 July 2023
|
04 October 2026
|
| View |
|
DRP-3892-09
|
Tramadol Hydrochloride
|
Tramacirc
|
100mg/2mL
|
Solution for Injection (IM/IV)
|
Opioid Analgesic
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
10 May 2027
|
| View |
|
DRP-3892-8
|
Tramadol Hydrochloride
|
Akidol
|
100 mg / 2 mL
|
Solution for Injection (IM/IV)
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
23 August 2023
|
10 May 2027
|
| View |
|
DRP-13238-01
|
Ursodeoxycholic Acid
|
Ubile 250
|
250 mg
|
Capsule
|
-
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 May 2023
|
06 January 2028
|
| View |
|
DRP-13238-3
|
Ursodeoxycholic Acid
|
Ursover 250
|
250 mg
|
Capsule
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 May 2023
|
06 January 2028
|
| View |
|
DRP-13237-02
|
Ursodeoxycholic Acid
|
Ubile 500
|
500 mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 May 2023
|
06 January 2028
|
| View |
|
DRP-13237-3
|
Ursodeoxycholic Acid
|
Ursover 500
|
500 mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 May 2023
|
06 January 2028
|
| View |
|
DRP-4968-01
|
Amlodipine (as besilate)
|
Mybloc-5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Ravian Life Science Pvt. Ltd
|
India
|
Renewal
|
02 November 2023
|
29 November 2028
|
| View |
|
DRP-5412-08
|
Methylprednisolone
|
Zelpred-K
|
16 mg
|
Tablet
|
Corticosteroid (Glucocorticoid)
|
Healer's Lab (Unit II)
|
India
|
Renewal
|
15 August 2024
|
04 August 2029
|
| View |
|
DRP-9149
|
Bortezomib
|
None
|
3.5 mg
|
Lyophilized Powder For Injection (I.V./S.C.)
|
-
|
|
|
Initial (Variation)
|
15 November 2022
|
18 September 2025
|
| View |
|
DRP-4895-05
|
Etoricoxib
|
Etorigen
|
90 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Scott-Edil Pharmacia Ltd
|
India
|
Renewal
|
31 October 2023
|
07 November 2028
|
| View |
|
DRP-10812-01
|
Calcipotriol (as monohydrate) + Betamethasone (as dipropionate)
|
Dipsotrex B
|
50 mcg / 500 mcg
|
Ointment
|
Antipsoriatic
|
Genuone Sciences Inc
|
Korea
|
CLIDP Conversion
|
01 August 2023
|
01 December 2026
|
| View |
|
DRP-11361-02
|
Cefuroxime (as sodium)
|
Cefuromax
|
750mg
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
31 March 2023
|
04 March 2027
|
| View |
|
DRP-11361-03
|
Cefuroxime (as sodium)
|
TGCef IV
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
26 April 2023
|
04 March 2027
|
| View |
|
DRP-11898-02
|
Ceftriaxone (as sodium)
|
TGXone
|
1g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
17 March 2023
|
18 May 2027
|
| View |
|
DRP-11898-03
|
Ceftriaxone (as sodium)
|
Trimaxone
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
30 March 2023
|
18 May 2027
|